Citations for
1TSG22A
Fine mapping of familial prostate cancer families narrows the interval for a susceptibility locus on chromosome 22q12.3 to 1.36 Mb.
Johanneson B, McDonnell SK, Karyadi DM, Hebbring SJ, Wang L, Deutsch K, McIntosh L, Kwon EM, Suuriniemi M, Stanford JL, Schaid DJ, Ostrander EA, Thibodeau SN.
Hum Genet 123(1):65-75. Epub 2007 Dec 8. 2008
2TSG22A
Identification of recurrent regions of chromosome loss and gain in vestibular schwannomas using comparative genomic hybridisation.
Warren C, James LA, Ramsden RT, Wallace A, Baser ME, Varley JM, Evans DG.
J Med Genet 40(11):802-6. 2003
3TSG22A
Loss of heterozygosity on chromosome 22 in human ependymomas.
Huang B, Starostik P, Kuhl J, Tonn JC, Roggendorf W.
Acta Neuropathol (Berl) 103(4):415-20. Epub 2002 Jan 17. 2002
4TSG22A
Indications for a tumor suppressor gene at 22q11 involved in the pathogenesis of ependymal tumors and distinct from hSNF5/INI1.
Kraus JA, de Millas W, Sorensen N, Herbold C, Schichor C, Tonn JC, Wiestler OD, von Deimling A, Pietsch T.
Acta Neuropathol (Berl) 102(1):69-74. 2001
5NF2, TSG22A
Frequent mutations of NF2 and allelic loss from chromosome band 22q12 in malignant mesothelioma : evidence for a two-hit mechanism of NF2 inactivation.
Cheng JQ, et al.
Genes Chromosomes Cancer 24 : 238-242. 1999
6NF2, TSG22A
Merlin: the neurofibromatosis 2 tumor suppressor.
Gusella JF, et al.
Biochim Biophys Acta 1423(2):M29-36. Review. 1999
7TSG22A, BIK
Mapping of a target region of allelic loss to a 0.5-cM interval on chromosome 22q13 in human colorectal cancer.
Castells A, Ino Y, Louis DN, Ramesh V, Gusella JF, Rustgi AK.
Gastroenterology 117(4):831-7. 1999
8NF2, TSG22A
Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas.
Ueki K, Wen-Bin C, Narita Y, Asai A, Kirino T.
Cancer Res 59(23):5995-8. 1999
9NF2, TSG22A
Neurofibromatosis 2 tumour suppressor schwannomin interacts with betaII-spectrin.
Scoles DR, et al.
Nat Genet 18 : 354-359. 1998
10NF2, TSG22A
The involvement of calpain-dependent proteolysis of the tumor suppressor NF2 (merlin) in schwannomas and meningiomas.
Kimura Y, et al.
Nat Med 4 : 915-922. 1998
11NF2, SCWT, TSG22A
Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis.
Jacoby LB, Jones D, Davis K, Kronn D, Short MP, Gusella J, MacCollin M.
Am J Hum Genet 61(6):1293-302. 1997
12NF2, TSG22A
Identification of three neurofibromatosis type 2 (NF2) gene mutations in vestibular schwannomas.
Sainz J, et al.
Hum Genet 97 : 121-123. 1996
13NF2, TSG22A
Screening for mutations in the neurofibromatosis type 2 (NF2) gene in sporadic meningiomas.
De Vitis LR, et al.
Hum Genet 97 : 632-637. 1996
14NF2, TSG22A
Analysis of the neurofibromatosis type 2 gene in different human tumors of neuroectodermal origin.
De Vitis LR, et al.
Hum Genet 97 : 638-641. 1996
15TSG22A, NF2
Mutational spectrum in the neurofibromatosis type 2 gene in sporadic and familial schwannomas.
Welling DB, et al.
Hum Genet 98 : 189-193. 1996
16TSG17D, TSG22A
Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic pediatric ependymomas.
von Haken MS, et al.
Genes Chromosomes Cancer 17 : 37-44. 1996
17NF2, TSG22A
High frequency of nonsense mutations in the NF2 gene caused by C to T transitions in five CGA codons.
Sainz J, et al.
Hum Mol Genet 4 : 137-139. 1995
18NF2, TSG22A
Somatic mutations in the neurofibromatosis type 2 gene in sporadic meningiomas.
Papi L, et al.
Hum Genet 95 : 347-351. 1995
19TSG22A, NF2
High frequency of inactivating mutations in the neurofibromatosis type 2gene (NF2) in primary malignant mesotheliomas.
Bianchi AB, et al.
Proc Natl Acad Sci U S A 92 : 10854-10858. 1995
20TSG22A
NF2 gene analysis distinguishes hemangiopericytoma from meningioma.
Joseph JT, et al.
Am J Pathol 147 : 1450-1455. 1995
21TSG22A
Frequent loss of heterozygosity at telomeric loci on 22q in sporadic colorectal cancers.
Yana I, et al.
Int J Cancer 60 : 174-177. 1995
22TSG22A, NF2
Analysis of the NF2 tumor-suppressor gene and of chromosome 22 deletions in gliomas.
Hoang-Xuan K, et al.
Int J Cancer 60 : 478-481. 1995
23TSG22A
Deletion mapping of the long arm of chromosome 22 in human meningiomas.
Akagi K, et al.
Int J Cancer 60 : 178-182. 1995
24NF2, TSG22A
Eleven novel mutations in the NF2 tumour suppressor gene.
Bourn D, et al.
Hum Genet 95 : 572-574. 1995
25TSG6B, KLF6, TSG13B, TSG22A, TSG17D, TSG19A
Molecular analysis of genetic changes in ependymomas.
Bijlsma EK, et al.
Genes Chromosomes Cancer 13 : 272-277. 1995
26TSG22A, NF2
Screening for germ-line mutations in the NF2 gene.
Mˇrel P, et al.
Genes Chromosomes Cancer 12 : 117-127. 1995
27TSG22A
Constitutional DNA-level aberrations in chromosome 22 in a patient with multiple meningiomas.
Lekanne Deprez RH, et al.
Genes Chromosomes Cancer 9 : 124-128. 1994
28TSG22A
Abnormalities of chromosome 22 in pediatric meningiomas.
Biegel JA, et al.
Genes Chromosomes Cancer 9 : 81-87. 1994
29TSG22A
Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas.
Ruttledge MH, et al.
Nat Genet 6 : 180-184. 1994
30NF2, TSG22A
Somatic NF2 gene mutations in familial and non-familial vestibular schwannoma.
Irving RM, et al.
Hum Mol Genet 3 : 347-350. 1994
31NF2, TSG22A
The neurofibromatosis type 2 gene is inactivated in schawnnomas.
Twist EC, et al.
Hum Mol Genet 3 : 147-151. 1994
32TSG22A
Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas.
Rubio MP, et al.
Cancer Res 54 : 45-47. 1994
33NF2, TSG22A
Exon scanning for mutation of the NF2 gene in schwannomas.
Jacoby LB, et al.
Hum Mol Genet 3 : 413-419. 1994
34TSG1A, TSG22A
Allelic loss at Ip is associated with tumor progression of meningiomas.
Bello MJ, et al.
Genes Chromosomes Cancer 9 : 296-298. 1994
35NF2, TSG22A
Alternative splicing of the NF2 gene and its mutation analysis of breast and colorectal cancers.
Arakawa H, et al.
Hum Mol Genet 3 : 565-568. 1994
36NF2, TSG22A
Germline mutations in the neurofibromatosis type 2 tumour suppressor gene.
Bourn D, et al.
Hum Mol Genet 3 : 813-816. 1994
37TSG22A, NF2
Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas.
Sainz J, et al.
Hum Mol Genet 3 : 885-891. 1994
38TSG22A, NF2
Characterization of the translocation breakpoint on chromosome 22q12.2 in a patient with neurofibromatosis type 2 (NF2).
Arai E, et al.
Hum Mol Genet 3 : 937-939. 1994
39TSG22A
Deletions on chromosome 22 in sporadic meningioma.
Ruttledge MH, et al.
Genes Chromosomes Cancer 10 : 122-130. 1994
40TSG22A, NF2
Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas.
Lekanne Deprez RH, et al.
Am J Hum Genet 54 : 1022-1929. 1994
41TSG22A, LIF
Analysis of chromosome 22 loci in meningioma.
Pergolizzi RG, et al.
Mol Chem Neuropathol 21 : 189-217. 1994
42NF2, TSG22A
A mutation in the neurofibromatosis type 2 tumor-suppressor gene, giving rise to widely different clinical phenotypes in two unrelated individuals.
Bourn D, et al.
Am J Hum Genet 55 : 69-73. 1994
43TSG22A, NF2
Molecular genetic analysis of the mechanism of tumorigenesis in acoustic neuroma.
Irving RM, et al.
Arch Otolaryngol Head Neck Surg 119 : 1222-1228. 1993
44NF2, TSG22A
Analysis of chromosome 22 deletions in neurofibromatosis type 2-related tumors.
Wolff RK, et al.
Am J Hum Genet 51 : 478-485. 1992
45TSG22A
Molecular characterization of chromosome 22 deletions in schwannomas.
Bijlsma EK, et al.
Genes Chromosomes Cancer 5 : 201-205. 1992
46TSG22A, TSG22D
Abnormalities of chromosome 22 in human brain tumors determined by combined cytogenetic and molecular genetic approaches.
Rey JA, et al.
Cancer Genet Cytogenet 66 : 1-10. 1992
47TSG22A, TSG22B
Loss of heterozygosity on the long arm of chromosome 22 in pheochromocytoma.
Tanaka N, et al.
Genes Chromosomes Cancer 5 : 399-403. 1992
48MGCR, TSG22A
Molecular genetic analysis of chromosome 22 in 81 cases of meningioma.
Dumanski JP, et al.
Cancer Res 50 : 5863-5867. 1990
49MGCR, TSG22A, TSG22B
Chromosome 22q deletions in meningiomas detected by RFLP analysis.
Dumanski JP, et al.
(HGM9) Cytogenet Cell Genet 46 : 608. 1987
50MGCR, TSG22A, TSG22B
Molecular genetic approach to human meningioma : loss of genes on chromosome 22.
Seizinger BR, et al.
Proc Natl Acad Sci U S A 84 : 5419-5423. 1987